GeneBioTech Co. ,Ltd (KOSDAQ:086060)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,030.00
+260.00 (5.45%)
At close: Feb 13, 2026
Market Cap43.31B +46.9%
Revenue (ttm)92.28B +14.6%
Net Income3.68B +44.3%
EPS427.53 +44.4%
Shares Out8.61M
PE Ratio11.77
Forward PEn/a
Dividend50.00 (0.99%)
Ex-Dividend DateDec 29, 2025
Volume3,997,456
Average Volume436,552
Open4,630.00
Previous Close4,770.00
Day's Range4,630.00 - 5,940.00
52-Week Range3,015.00 - 5,990.00
Beta0.47
RSI84.35
Earnings DateMar 13, 2026

About GeneBioTech Co. ,Ltd

GeneBioTech Co. ,Ltd, together with its subsidiaries, engages in the manufacture and sale of feed additives and functional food in South Korea. It also manufactures and sells animal drugs. The company was founded in 2000 and is headquartered in Gongju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2000
Employees 42
Stock Exchange KOSDAQ
Ticker Symbol 086060
Full Company Profile

Financial Performance

In 2024, GeneBioTech Co. ,Ltd's revenue was 82.96 billion, an increase of 4.38% compared to the previous year's 79.48 billion. Earnings were 2.87 billion, an increase of 10.57%.

Financial Statements